Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2020

Jul 21, 2020

SELL
$13.31 - $20.51 $624,864 - $962,882
-46,947 Closed
0 $0
Q1 2020

Oct 03, 2024

BUY
$12.98 - $30.25 $609,372 - $1.42 Million
46,947 New
46,947 $728,000
Q1 2020

Apr 29, 2020

SELL
$12.98 - $30.25 $3.31 Million - $7.71 Million
-254,971 Reduced 84.45%
46,947 $728,000
Q4 2019

Oct 03, 2024

BUY
$18.89 - $31.89 $5.7 Million - $9.63 Million
301,918 New
301,918 $9.03 Million
Q4 2019

Jan 17, 2020

SELL
$18.89 - $31.89 $14 Million - $23.6 Million
-738,872 Reduced 70.99%
301,918 $9.03 Million
Q3 2019

Oct 03, 2024

BUY
$20.88 - $25.66 $21.7 Million - $26.7 Million
1,040,790 New
1,040,790 $22.7 Million
Q3 2019

Oct 17, 2019

SELL
$20.88 - $25.66 $285,972 - $351,439
-13,696 Reduced 1.3%
1,040,790 $22.7 Million
Q2 2019

Oct 03, 2024

BUY
$20.52 - $26.45 $21.6 Million - $27.9 Million
1,054,486 New
1,054,486 $26.6 Million
Q2 2019

Jul 23, 2019

BUY
$20.52 - $26.45 $5.6 Million - $7.21 Million
272,702 Added 34.88%
1,054,486 $26.6 Million
Q1 2019

Oct 03, 2024

BUY
$20.23 - $26.29 $15.8 Million - $20.6 Million
781,784 New
781,784 $19.3 Million
Q1 2019

May 13, 2019

BUY
$20.23 - $26.29 $395,739 - $514,284
19,562 Added 2.57%
781,784 $19.3 Million
Q4 2018

Oct 03, 2024

BUY
$17.64 - $28.32 $13.4 Million - $21.6 Million
762,222 New
762,222 $14.1 Million
Q4 2018

Feb 06, 2019

BUY
$17.64 - $28.32 $371,798 - $596,900
21,077 Added 2.84%
762,222 $14.1 Million
Q3 2018

Oct 04, 2024

BUY
$20.64 - $25.67 $15.3 Million - $19 Million
741,145 New
741,145 $19 Million
Q3 2018

Nov 13, 2018

BUY
$20.64 - $25.67 $15.3 Million - $19 Million
741,145 New
741,145 $19 Million

Others Institutions Holding BHC

About Bausch Health Companies Inc.


  • Ticker BHC
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 361,728,000
  • Market Cap $2.7B
  • Description
  • Bausch Health Companies Inc., together with its subsidiaries, develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. The company operates through five segments: Bausch + Lomb, Salix, International Rx, O...
More about BHC
Track This Portfolio

Track Commerzbank Aktiengesellschaft Portfolio

Follow Commerzbank Aktiengesellschaft and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Commerzbank Aktiengesellschaft , based on Form 13F filings with the SEC.

News

Stay updated on Commerzbank Aktiengesellschaft with notifications on news.